FDA issued its first emergency use authorization for a rapid COVID-19 diagnostic that can be performed entirely at home late Tuesday (Nov. 18) night and hopes to approve similar tests in the upcoming weeks. An EUA template for at-home tests should be available shortly, an agency official said. The newly authorized test, developed by Lucira Health, uses self-collected nasal swabs to collect samples that are then placed in a test unit. The results can be read as soon as 11...